EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Adherence to Potassium Citrate, Changes in 24-Hour Stone Risk Parameters, and Recurrent Kidney Stone Events

Joseph J Crivelli, Mary K Oerline iD, Naim M Maalouf, Ryan S Hsi, Noah A Krampe, Kevin B Smith iD, Sara L Best iD, Brian T Denton iD, Vahakn B Shahinian iD, John M Hollingsworth

Kidney360 · 2026-07 · 7 (7) · 1625-1632

DOI: 10.34067/kid.0000001157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, online erschienen am 03.03.2026. Verfasst von Joseph J Crivelli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Birmingham Veterans Affairs Medical Center, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alaba…. Hauptthemen laut MEDLINE: Potassium Citrate, Kidney Calculi, Drug Monitoring. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Pharmacy claims–based adherence (percentage of days covered) and urine-based adherence (change in urinary potassium excretion divided by dose) showed discordant associations with physiologic response and recurrence. Although change in urinary potassium excretion divided by dose was more strongly associated with changes in urinary citrate and pH, only percentage of days covered was significantly associated with recurrent stone events.

Background

Patient adherence limits the effectiveness of preventive pharmacologic therapy (PPT) for urinary stone disease, highlighting the need for accurate adherence monitoring. We assessed associations between potassium citrate adherence measures, changes in 24-hour urine parameters, and the risk of recurrent stone events.

Methods

In this retrospective cohort study, we identified adult patients enrolled in Medicare with urinary stone disease, a baseline 24-hour urine collection (2010–2019), hypocitraturia or low urine pH, a prescription for potassium citrate monotherapy, and a follow-up urine collection. We defined two adherence measures: ( 1 ) percentage of days covered (PDC) using pharmacy claims and ( 2 ) change in urinary potassium between baseline and follow-up divided by medication dose (change in urinary potassium excretion divided by dose [ΔK/dose]). We assessed the association of these measures with changes in urinary citrate and pH using analysis of covariance, and the association between adherence and recurrent stone events using Cox models.

Results

Among 793 patients meeting the study criteria, 504 (63.6%) patients were adherent on the basis of pharmacy claims (PDC ≥80%) and 389 (49.1%) patients on the basis of ΔK/dose ≥0.5. Compared with PDC ≥80%, ΔK/dose ≥0.5 had a stronger association with change in urinary citrate ( P < 0.001) and pH ( P < 0.001). Compared with PDC ≥80%, patients with PDC

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Potassium CitrateKidney CalculiDrug MonitoringHumansFemaleRetrospective StudiesMaleAgedRecurrenceMiddle AgedPotassiumCitric AcidUnited StatesHydrogen-Ion Concentration

Stichwörter der Autor:innen

kidney stones

Substanzen

Potassium CitratePotassiumCitric Acid

Autor:innen und Institutionen

  • Department of Urology, Birmingham Veterans Affairs Medical Center, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama.
  • Dow Division of Health Services Research, Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan.
  • Department of Internal Medicine and Charles, Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Department of Urology, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Department of Industrial and Operations Engineering, University of Michigan School of Engineering, Ann Arbor, Michigan.

ORCID-Profile: Mary K Oerline, Kevin B Smith, Sara L Best, Brian T Denton, Vahakn B Shahinian

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Crivelli, J. J., Oerline, M. K., Maalouf, N. M., Hsi, R. S., Krampe, N. A., Smith, K. B., Best, S. L., Denton, B. T., Shahinian, V. B., & Hollingsworth, J. M. (2026). Adherence to Potassium Citrate, Changes in 24-Hour Stone Risk Parameters, and Recurrent Kidney Stone Events. Kidney360, 7(7), 1625-1632. https://doi.org/10.34067/kid.0000001157

Vancouver

Crivelli JJ, Oerline MK, Maalouf NM, Hsi RS, Krampe NA, Smith KB, et al. Adherence to Potassium Citrate, Changes in 24-Hour Stone Risk Parameters, and Recurrent Kidney Stone Events. Kidney360. 2026;7(7):1625-1632. doi:10.34067/kid.0000001157

BibTeX
@article{Crivelli2026,
  author = {Crivelli, Joseph J and Oerline, Mary K and Maalouf, Naim M and Hsi, Ryan S and Krampe, Noah A and Smith, Kevin B and Best, Sara L and Denton, Brian T and Shahinian, Vahakn B and Hollingsworth, John M},
  title = {Adherence to Potassium Citrate, Changes in 24-Hour Stone Risk Parameters, and Recurrent Kidney Stone Events},
  journal = {Kidney360},
  year = {2026},
  volume = {7},
  number = {7},
  pages = {1625--1632},
  doi = {10.34067/kid.0000001157}
}
Kostenlos starten →